Format

Send to

Choose Destination
Sci Rep. 2015 Oct 12;5:14600. doi: 10.1038/srep14600.

Obesity changes the human gut mycobiome.

Author information

1
Department of Diabetes, Endocrinology and Nutrition, Institut d'Investigacio´ Biomèdica de Girona (IdIBGi), CIBEROBN (CB06/03/010) and Instituto de Salud Carlos III (ISCIII), Girona, Spain.
2
Genotyping and Genetic Diagnosis Unit, Fundación de Investigación del Hospital Clínico de Valencia-INCLIVA, Valencia, Spain.
3
Hospital Universitari de Tarragona Joan XXIII. IISPV. CIBERDEM. Universitat Rovira i Virgili. Tarragona Spain.
4
Departamento de Medicina Experimental, Universitat de Lleida-IRBLleida. Lleida, Spain.

Abstract

The human intestine is home to a diverse range of bacterial and fungal species, forming an ecological community that contributes to normal physiology and disease susceptibility. Here, the fungal microbiota (mycobiome) in obese and non-obese subjects was characterized using Internal Transcribed Spacer (ITS)-based sequencing. The results demonstrate that obese patients could be discriminated by their specific fungal composition, which also distinguished metabolically "healthy" from "unhealthy" obesity. Clusters according to genus abundance co-segregated with body fatness, fasting triglycerides and HDL-cholesterol. A preliminary link to metabolites such as hexadecanedioic acid, caproic acid and N-acetyl-L-glutamic acid was also found. Mucor racemosus and M. fuscus were the species more represented in non-obese subjects compared to obese counterparts. Interestingly, the decreased relative abundance of the Mucor genus in obese subjects was reversible upon weight loss. Collectively, these findings suggest that manipulation of gut mycobiome communities might be a novel target in the treatment of obesity.

PMID:
26455903
PMCID:
PMC4600977
DOI:
10.1038/srep14600
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center